Florian H.
- Country
- Germany
- Department
- #2523:Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
Research Overview
- Phase 1 Evaluation of JNJ-88549968, a T-cell Redirecting Antibody, in Patients with CALR-mutated Myeloproliferative Neoplasms
- Phase 3 Randomized Double‑Blind Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo + Ruxolitinib in JAK‑Inhibitor‑Naive Adults with Myelofibrosis
- Phase 3 Evaluation of Venetoclax and Azacitidine Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients
Data & Insights
Has run more than one trial at 45 of 135 partner sites.
Specializations
Hematologic Malignancies
Specializes in treating various forms of acute myeloid leukemia (AML), with particular focus on relapsed and refractory cases. Investigates novel therapeutic approaches for chronic myeloid leukemia (CML) management.
- Post-transplant AML maintenance therapy
- Targeted therapies for resistant AML
- Novel CML treatment approaches
Explores combination therapies and innovative treatment strategies for improving patient outcomes in leukemia cases.
Myeloproliferative Disorders
Conducts research in myeloproliferative neoplasms, including primary and secondary myelofibrosis and essential thrombocythemia. Focuses on targeted therapeutic approaches for these chronic blood disorders.
- JAK-inhibitor resistant myelofibrosis
- CALR-mutated disorders
- Cytoreductive therapy optimization
Implements innovative treatment protocols for patients with various myeloproliferative conditions.
Solid Tumor Research
Investigates advanced therapeutic approaches for solid tumors, with emphasis on immunotherapy and cellular treatments. Explores novel CAR-T cell therapy applications combined with RNA-based vaccines.
- CLDN6-targeted therapies
- Combination immunotherapy approaches
- Cell therapy optimization
Develops personalized treatment strategies for various organ-based malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.